We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NVAX Novavax Inc

0.175 (3.14%)
Last Updated: 13:00:11
Delayed by 15 minutes


Draw Mode:

Volume 4,237,444
Bid Price 5.74
Ask Price 5.75
News -
Day High 5.77


52 Week Range


Day Low 5.531
Share Name Share Symbol Market Stock Type
Novavax Inc NVAX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.175 3.14% 5.745 13:00:11
Open Price Low Price High Price Close Price Previous Close
5.62 5.531 5.77 5.57
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
23,080 4,237,444 US$ 5.64 US$ 23,903,781 - 5.30 - 18.55
Last Trade Type Quantity Price Currency
13:00:33 158 US$ 5.745 USD

Novavax (NVAX) Options Flow Summary

Overall Flow


Net Premium


Calls / Puts


Buys / Sells




Sweeps Ratio


Novavax Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
673.54M 118.79M - 1.98B -657.94M -5.54 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Novavax News

Date Time Source News Article
12/05/202315:01PR Newswire (US)Novavax's Updated COVID-19 Vaccine Now Authorized in Canada
12/05/202307:45Edgar (US Regulatory)Form 8-K - Current report
11/28/202312:13IH Market NewsWall Street Radar: Amazon, Blackrock, General Motors, Eli..
11/28/202305:00PR Newswire (US)Novavax's Updated Protein-based COVID-19 Vaccine Now an..
11/17/202315:36Edgar (US Regulatory)Form 8-K - Current report
11/17/202306:15PR Newswire (US)Novavax Makes Changes to Executive Leadership Team to..
11/10/202308:25PR Newswire (US)Novavax to Participate in Jefferies London Healthcare..
11/09/202307:05Edgar (US Regulatory)Form 8-K - Current report
11/09/202307:00PR Newswire (US)Novavax Reports Third Quarter 2023 Financial Results and..
11/09/202306:32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202306:02IH Market NewsThursday’s Wall Street Highlights: Nvidia, Duolingo, Disney,..
11/08/202305:59IH Market NewsWednesday’s Wall Street Highlights: Spirit AeroSystems,..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No NVAX Message Board. Create One! See More Posts on NVAX Message Board See More Message Board Posts

Historical NVAX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.526.055.425.616,195,9680.2254.08%
1 Month6.276.515.305.695,705,133-0.525-8.37%
3 Months7.778.155.306.697,246,457-2.03-26.06%
6 Months7.6210.305.307.527,851,186-1.88-24.61%
1 Year16.74818.555.308.327,333,188-11.00-65.7%
3 Years118.80331.53885.3074.505,881,039-113.06-95.16%
5 Years44.40331.53883.5460.406,180,936-38.66-87.06%

Novavax Description

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |